logo

VYGR

Voyager Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

VYGR fundamentals

Voyager Therapeutics (VYGR) released its earnings on Nov 10, 2025: revenue was 13.37M (YoY -45.72%), beat estimates; EPS was -0.47 (YoY -193.75%), beat estimates.
Revenue / YoY
13.37M
-45.72%
EPS / YoY
-0.47
-193.75%
Report date
Nov 10, 2025
EPS
Revenue

Revenue & Expenses

VYGR has released its 2025 Q3 earnings report, with revenue of 13.37M, reflecting a YoY change of -45.73%, and net profit of -27.89M, showing a YoY change of -208.40%. The Sankey diagram below clearly presents VYGR's revenue sources and cost distribution.

Key Indicators

Voyager Therapeutics (VYGR) key financial stats and ratios, covering profitability, financial health, and leverage.
Voyager Therapeutics (VYGR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Voyager Therapeutics (VYGR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Voyager Therapeutics (VYGR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Voyager Therapeutics (VYGR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Voyager Therapeutics (VYGR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield